(1)
Antiarrhythmic Efficacy and Safety of 1C Class anti­­arrhythmic Agents Ethacizin and Propafenone in Patients With Arterial Hypertension and Frequent Recurrences of Atrial Fibrillation. UJC 2018, 25 (2), 43-49.